Computer kidney could provide safer tests for new medications
A University of Waterloo researcher has spearheaded the development of the first computational model of the human kidney.
Mar 11, 2019
0
66
A University of Waterloo researcher has spearheaded the development of the first computational model of the human kidney.
Mar 11, 2019
0
66
Stroke is a leading cause of death and chronic disability in adults, causing a heavy social and economic burden worldwide. However, no treatments exist to restore neuronal circuitry after a stroke. While most neurons are ...
Dec 12, 2018
0
7
Thrombosis-on-a-chip, vasculature-on-a-chip and engineered models of human cardiac fibrosis are just a few of the new technologies revolutionizing research into human cardiovascular disease—a condition responsible for 17 ...
Oct 24, 2018
0
0
Newly formed blood vessels may be cracks in the barrier between the bloodstream and the eye, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.
Sep 14, 2018
0
26
There are still comparatively few treatments available for brain diseases. Among other reasons, this is due to the difficulty of developing new drugs, as it is not easy to establish the effects and side effects of a substance ...
Jan 30, 2018
0
109
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal ...
Nov 2, 2017
0
347
The University of Manchester is part of a new consortium which will develop new CT and MRI scan techniques and biomarkers to look at the accumulation of compounds in the body caused by drugs and the harm they may cause—potentially ...
Apr 18, 2017
0
0
New research illustrates how "disease in a dish" stem cell technology can advance cardiology.
Sep 8, 2016
0
2
A research team spanning four continents has detailed the anti-viral capabilities of OSU-03012, also known as AR-12, a drug currently used in clinical trials to treat certain cancer tumors. The present study confirms that ...
Jul 5, 2016
0
96
The current business model for antibiotics is plagued by market failures and perverse incentives that both work against conservation efforts and provide insufficient rewards to drive the development of much-needed new treatments ...
Jun 14, 2016
0
0